Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

NUS Technology Holdings

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 1
Average round size
info
The average size of a deal this fund participated in
$6M
Portfolio companies 1
Rounds per year 0.04
Lead investments 0
Key employees Soon

Areas of investment

  • Health Care
  • Health Diagnostics
  • Biotechnology
Summary

NUS Technology Holdings is the famous Corporate Investor, which was founded in 1995. The main department of described Corporate Investor is located in the Singapore. The company was established in Asia in Singapore.

The usual cause for the fund is to invest in rounds with 6 partakers. The meaningful sponsors for the fund in investment in the same round are Vertex Ventures Southeast Asia & India, Vertex Ventures, Spring SEEDS Capital.

Among the most successful fund investment fields, there are Biotechnology, Health Diagnostics. Among the most popular portfolio startups of the fund, we may highlight Clearbridge Biomedics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Singapore.

The fund is generally included in less than 2 deals every year. Deals in the range of 5 - 10 millions dollars are the general things for fund. The average startup value when the investment from NUS Technology Holdings is 5-10 millions dollars. The important activity for fund was in 2013.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Anhui Xinhua Media Anhui, China, Hefei
Cascadia Partners Oregon, Portland, United States
Cognosante Mclean, United States, Virginia
Future Home Capital -
Honda Xcelerator California, Mountain View, United States
Kun Lun Stone Capital China, Guangdong, Shenzhen
Kyodo Printing Japan, Tokyo
Mavericks Founders Berlin, Berlin, Germany
New Science Ventures New York, New York, United States
NexGen Energy British Columbia, Canada, Vancouver
Nordic Angel Program -
One Team Collective -
Q Investments Fort Worth, Texas, United States
RRC Group Moscow, Moscow, Russia
ShengJing360 Beijing, Beijing, China
SZHTI Group China, Guangdong, Shenzhen
Tengram Capital Partners Connecticut, United States, Westport
TriplePoint Ventures California, Menlo Park, United States
Varsity Ventures California, Stanford, United States
Vivo Capital California, Palo Alto, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Biolidics

Biotechnology
Health Care
Health Diagnostics
$6M13 Mar 2013 Central

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent NUS Technology Holdings?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: